Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Country:  U.S.A.
Treatment/Intervention:  complementary or alternative medicine procedure
Results 1-25 of 66 for your search:
Start Over
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: MDA-04-01, NCI-2011-02073, CDR0000674208, WFU 97115, WF-97115, NCT01141231
Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Patients with Early-Stage Breast Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Postmenopausal
Trial IDs: S1200, NCI-2012-00251, CDR0000725249, SWOG-S1200, NCT01535066
Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: URCC14040, NCI-2015-01144, RSRB052271, NCT02613364
Irinotecan Hydrochloride with or without Chinese Herbal Formulation PHY906 in Treating Patients with Metastatic Colorectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 12-005, NCI-2016-00749, NCT00730158
Acupuncture or Gabapentin in Treating Breast Cancer Survivors With Hot Flashes
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 16108, NCI-2009-01315, NCT01005108
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: IOM-HNC-201-IL, NCI-2015-01924, NCT01400620
Combination Chemotherapy, Bevacizumab, and Cholecalciferol in Treating Patients with Previously Untreated Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-436, NCI-2012-00662, NCT01516216
Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents
Status: Active
Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Age: 11 to 24
Trial IDs: ANUR1131, NCI-2012-00682, CDR0000726664, COG-ANUR1131, NCT01556256
Ascorbic Acid, Gemcitabine Hydrochloride, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 75
Trial IDs: 11D.365, NCI-2012-00340, 2008-52(1), NCT01555489
Curcumin in Reducing Fatigue in Patients with Chemotherapy-Treated Breast Cancer Undergoing Radiotherapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: WINSHIP2139-11, NCI-2014-02195, IRB00055328, NCT01740323
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients with Localized Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 and over
Trial IDs: CO11378, NCI-2014-00695, N01-CN-2012-00033, UWI2013-00-01, NCT02095145
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GHNSCLC-2 001, NCI-2014-02209, NCT02047344
High-Dose Ascorbic Acid in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201412760, NCI-2015-00709, NCT02420314
Noni Extract in Treating Patients with Very Low Risk or Low Risk Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: Huang-2015-1, NCI-2016-00082, NCT02648919
Defined Green Tea Catechin Extract and Erlotinib Hydrochloride in Treating Patients with Premalignant Lesions or Previously Treated Early Stage Squamous Cell Cancer of the Head and Neck
Status: Active
Phase: Phase I
Type: Prevention
Age: 18 and over
Trial IDs: WCI1549-08, NCI-2011-03396, IRB00014010, WCI 1549, NCT01116336
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: CTAP101-CL-1017, NCI-2015-01720, NCT02274623
Calcitriol in Preventing Lung Cancer in High-Risk Patients
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 40 to 79
Trial IDs: I 90206, NCI-2013-00841, CDR0000596506, RPCI # I 90206, I 90205, NCT00690924
Vitamin E and Selenium in Preventing Cataracts and Age-Related Macular Degeneration
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology
Age: 55 and over (50 and over for African Americans)
Trial IDs: S0000B, NCI-2009-00751, CDR0000617778, SWOG-S0000B, NCT00784225
Cholecalciferol Supplement in Treating Patients with Localized Prostate Cancer Undergoing Observation
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 128308, NCI-2009-01530, RPCI-I-128308, NCT00887432
Short-Term Fasting in Reducing Side Effects in Patients Receiving Gemcitabine Hydrochloride and Cisplatin for Advanced Solid Tumors
Status: Active
Phase: No phase specified
Type: Supportive care
Age: Over 18
Trial IDs: 0S-08-9, NCI-2010-00357, HS-09-00010, NCT00936364
Mindfulness-Based Addiction Treatment in Treating Patients With Nicotine Dependence
Status: Active
Phase: No phase specified
Type: Behavioral study, Prevention
Age: 18 and over
Trial IDs: 2004-0988, NCI-2012-02081, NCT00297479
Sulforaphane in Treating Patients With Atypical Nevi Previously Diagnosed With Melanoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 10-114, NCI-2013-00057, NCT01568996
Start Over